Preclinical development and characterization of MYC inhibitors

被引：0
|
作者：
Jacob, Nicholas [1 ]
Miranda, Pedro [1 ]
Navarro, Pedro Serrano [1 ]
Hart, Jonathan [1 ]
Vogt, Peter [1 ]
Janda, Kim [1 ]
机构：
[1] Scripps Res Inst, San Diego, CA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 253卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
370
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Farnesyltransferase inhibitors - Preclinical development
    Kohl, NE
    ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN, 1999, 886 : 91 - 102
  • [2] Tyrosine kinase inhibitors in preclinical development
    Levitt, ML
    Koty, PP
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (03) : 213 - 226
  • [3] Tyrosine Kinase Inhibitors in Preclinical Development
    Mark L. Levitt
    Patrick P. Koty
    Investigational New Drugs, 1999, 17 : 213 - 226
  • [4] Development and Characterization of Benzoselenazole Derivatives as Potent and Selective c-MYC Transcription Inhibitors
    Wu, Tian-Ying
    Chen, Xiu-Cai
    Tang, Gui-Xue
    Shao, Wen
    Li, Zhang-Chi
    Chen, Shuo-Bin
    Huang, Zhi-Shu
    Tan, Jia-Heng
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (08) : 5484 - 5499
  • [5] Preclinical validation of Myc inhibition by a new generation of Omomyc-based inhibitors
    Beaulieu, Marie-Eve
    Jauset, Toni
    Masso-Valles, Daniel
    Whitfield, Jonathan
    Serrano, Erika
    Montagne, Martin
    Lavigne, Pierre
    Villaverde, Antonio
    Pesarrodona, Mireia
    Vazquez, Esther
    Soucek, Laura
    CANCER RESEARCH, 2015, 75
  • [6] Development and characterization of a c-Myc-driven preclinical mouse model of osteosarcoma to investigate the tumor immune microenvironment
    Nirala, Bikesh K.
    Kurenbekova, Lyazat
    Shuck, Ryan L.
    Patel, Tajhal
    Rajapakshe, Kimal
    Yustein, Jason T.
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Preclinical development of metalloproteasis inhibitors in cancer therapy
    Giavazzi, R
    Taraboletti, G
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 37 (01) : 53 - 60
  • [8] Preclinical and clinical development of CDK inhibitors.
    Senderowicz, AM
    CLINICAL CANCER RESEARCH, 2000, 6 : 4482S - 4482S
  • [9] Preclinical and clinical development of CDK inhibitors.
    Senderowicz, AM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B141 - B141
  • [10] Preclinical Development Of a Nanomedicne Approach For Multiple Myeloma Targeting The Myc Oncoprotein
    Soodgupta, Deepti
    Pan, Dipanjan
    Hu, Grace
    Senpan, Angana
    Yang, Xiaoxia
    Weilbaecher, Katherine N.
    Prochownik, Edward V.
    Lanza, Gregory M.
    Tomasson, Michael H.
    BLOOD, 2013, 122 (21)
12345